NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

RGEN

Repligen Corp

Jul 01 • 04:00PM ET

126.44

Dollar change +2.06
Percentage change 1.66	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: BIO TMO DHR WAT ILMN BRKR TECH MTD QGEN A

| Held by: IJH VTI VB VXF VBK MDY IBB FBT SPMD IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.41	Insider Own	5.46%	Shs Outstand	56.18M	Perf Week	2.51%
Market Cap	7.10B	Forward P/E	57.85	EPS next Y	2.19	Insider Trans	-1.70%	Shs Float	53.12M	Perf Month	7.09%
Enterprise Value	7.09B	PEG	-	EPS next Q	0.39	Inst Own	102.45%	Short Float	6.38%	Perf Quarter	-0.63%
Income	-22.98M	P/S	10.92	EPS this Y	6.71%	Inst Trans	2.06%	Short Ratio	3.99	Perf Half Y	-13.27%
Sales	650.43M	P/B	3.58	EPS next Y	29.63%	ROA	-0.81%	Short Interest	3.39M	Perf YTD	-12.16%
Book/sh	35.34	P/C	10.19	EPS next 5Y	21.24%	ROE	-1.16%	52W High	182.52 -30.73%	Perf Year	-0.12%
Cash/sh	12.41	P/FCF	59.33	EPS past 3/5Y	- -	ROIC	-0.87%	52W Low	102.96 22.80%	Perf 3Y	-23.78%
Dividend Est.	-	EV/EBITDA	56.93	Sales past 3/5Y	-1.83% 18.61%	Gross Margin	46.39%	Volatility	3.91% 3.96%	Perf 5Y	11.76%
Dividend TTM	-	EV/Sales	10.90	EPS Y/Y TTM	-196.93%	Oper. Margin	4.15%	ATR (14)	5.14	Perf 10Y	210.66%
Dividend Ex-Date	-	Quick Ratio	5.79	Sales Y/Y TTM	4.88%	Profit Margin	-3.53%	RSI (14)	52.32	Recom	1.57
Dividend Gr. 3/5Y	- -	Current Ratio	6.79	EPS Q/Q	76.84%	SMA20	0.71%	Beta	1.05	Target Price	182.24
Payout	-	Debt/Eq	0.34	Sales Q/Q	10.44%	SMA50	-1.53%	Rel Volume	0.74	Prev Close	124.38
Employees	1778	LT Debt/Eq	0.34	Earnings	Apr 29 BMO	SMA200	-10.59%	Avg Volume	850.57K	Price	126.44
IPO	Apr 29, 1986	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.68% 3.35%	Trades		Volume	633,560	Change	1.66%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-24-25	Initiated	Barclays	Overweight	$150
Apr-29-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$160
Mar-18-25	Initiated	Evercore ISI	In-line	$155
Feb-10-25	Initiated	TD Cowen	Buy	$200
Dec-17-24	Initiated	Canaccord Genuity	Hold	$165
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$241
Aug-24-20	Reiterated	H.C. Wainwright	Buy	$151 → $168
Jun-30-20	Reiterated	H.C. Wainwright	Buy	$143 → $151

Show Previous Ratings

Jun-24-25 02:18PM	5 Insightful Analyst Questions From Repligen's Q1 Earnings Call (StockStory)
Jun-16-25 08:00AM	908 Devices Appoints Christopher D. Brown to its Board of Directors (Business Wire)
Jun-04-25 11:36PM	Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-03-25 11:32PM	Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers (StockStory)
Jun-02-25 01:36PM	Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? (Zacks)
11:30AM	Loading…
May-29-25 11:30AM	Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? (Zacks)
May-27-25 07:30AM	Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report (GlobeNewswire)
May-22-25 07:30AM	Repligen Corporation to Present at William Blair Growth Conference (GlobeNewswire)
May-09-25 12:36AM	1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
May-07-25 07:30AM	Repligen Corporation to Present at Upcoming May Investor Conferences (GlobeNewswire)
May-02-25 11:40AM	QGEN or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
08:18AM	Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare (Insider Monkey)
May-01-25 12:11PM	Jim Cramer on Repligen Corporation (RGEN): 'I'm Not Quite Ready to Stick My Neck Out on This One' (Insider Monkey)
Apr-30-25 04:19PM	RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty (StockStory)
10:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
09:07AM	Loading…
09:07AM	Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y (Zacks)
03:09AM	Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 11:50PM	Q1 2025 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
12:58PM	Repligen Corporation (RGEN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:45AM	Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:05AM	Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:45AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-28-25 07:08PM	What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings (GuruFocus.com)
03:08AM	Repligen (RGEN) Q1 Earnings: What To Expect (StockStory)
Apr-25-25 09:16AM	3 Healthcare Stocks That Concern Us (StockStory)
Apr-23-25 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline (Zacks)
Apr-22-25 10:01AM	Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) +5.54%
Apr-16-25 11:40AM	GMAB or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
07:30AM	Loading…
Apr-15-25 07:30AM	Repligen to Report First Quarter 2025 Financial Results (GlobeNewswire)
Apr-10-25 05:03AM	Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory) -6.99%
Apr-08-25 07:30AM	Repligen Appoints Jacob Johnson As Vice President Investor Relations (GlobeNewswire) -6.22%
04:11AM	Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Mar-28-25 01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-25-25 12:46PM	Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? (Insider Monkey)
Mar-20-25 07:52AM	Repligen: Ongoing Bioprocessing Market Recovery (SeekingAlpha)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-12-25 05:01AM	Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks (StockStory)
Mar-11-25 05:01AM	A Look Back at Drug Development Inputs & Services Stocks Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack (StockStory) +7.40%
Mar-10-25 08:06PM	Analyst Report: Repligen Corporation (Morningstar Research) -12.02%
Mar-06-25 08:02AM	3 Small-Cap Stocks Skating on Thin Ice (StockStory)
Mar-05-25 05:14AM	Q4 2024 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents)
Mar-04-25 01:26PM	908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth (Benzinga)
07:30AM	Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices (Business Wire)
Feb-21-25 04:28PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:06AM	Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:24AM	Q4 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-20-25 07:21PM	Analyst Report: Repligen Corporation (Morningstar Research) +7.92%
02:00PM	Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook (Benzinga)
08:54AM	What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings (GuruFocus.com)
08:45AM	Repligen (RGEN) Beats Q4 Earnings Estimates (Zacks)
08:08AM	Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates (StockStory)
07:50AM	Repligen: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-19-25 08:05AM	Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow (StockStory)
Feb-12-25 08:44PM	Analyst Report: Repligen Corporation (Morningstar Research)
11:17AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Feb-11-25 07:30AM	Repligen to Report Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-29-25 03:19AM	Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains? (Zacks)
Jan-13-25 07:18PM	Analyst Report: Repligen Corporation (Morningstar Research)
Jan-07-25 07:30AM	Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-06-25 07:30AM	Repligen Launches the CTech SoloVPE PLUS System (GlobeNewswire)
Dec-20-24 09:21AM	Repligen Corporation (RGEN) Fell Along with Peers (Insider Monkey)
Dec-18-24 09:40PM	Analyst Report: Repligen Corporation (Morningstar Research) -6.83%
Dec-16-24 07:43PM	Analyst Report: Repligen Corporation (Morningstar Research)
08:11AM	BioLife Solutions Appoints Tony J. Hunt to its Board of Directors (PR Newswire)
Dec-12-24 11:30AM	Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? (Zacks)
07:30AM	Repligen Announces Publication of the Company's 2023 Corporate Sustainability Report (GlobeNewswire)
Dec-09-24 09:03AM	Several Factors Lifted Repligen Corporation (RGEN) in Q3 (Insider Monkey)
07:30AM	Repligen Launches Novel AVIPure dsRNA Resin in OPUS Pre-packed Columns (GlobeNewswire)
Nov-13-24 09:54AM	Analyst Report: Repligen Corporation (Morningstar Research)
02:37AM	Q3 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
02:08AM	Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-12-24 11:55AM	Repligen Stock Soars 10% on Record Growth and Bold Moves (GuruFocus.com) +6.51%
09:05AM	Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates (Zacks)
08:00AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 07:04AM	Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Nov-05-24 07:30AM	Repligen Corporation to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-31-24 07:30AM	Repligen to Report Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-22-24 10:01AM	Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release (Zacks)
Oct-15-24 12:45PM	3 investable themes, categories outside of the AI trade (Yahoo Finance Video)
Oct-04-24 11:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Oct-03-24 11:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
Sep-24-24 07:30AM	Repligen Opens Training & Innovation Center to Elevate Customer Experience (GlobeNewswire)
Sep-11-24 06:35AM	Several Headwinds Dragged Repligen Corporation (RGEN) in Q2 (Insider Monkey)
Sep-09-24 05:20AM	Reasons for the Decline of Repligen (RGEN) in Q2 (Insider Monkey)
Sep-07-24 07:37AM	Repligen Corporation (RGEN) Fell Due to CEO Transition (Insider Monkey)
Aug-29-24 11:31AM	Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Aug-23-24 08:43AM	Repligen Corporation (RGEN) Benefitted From Drug Approval (Insider Monkey)
07:30AM	Repligen Corporation to Present at Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-16-24 04:39AM	Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)? (Insider Monkey) -9.26%
Aug-02-24 07:09AM	Here's Why Shares in This Hot Healthcare Stock Surged This Week (Motley Fool)
Jul-31-24 10:46AM	Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates (Zacks)
12:30AM	Q2 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Jul-30-24 08:45AM	Repligen (RGEN) Q2 Earnings Meet Estimates (Zacks) +16.37%
07:45AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2024 Financial Results (GlobeNewswire)
02:55AM	Should You Consider Investing in Repligen Corporation (RGEN)? (Insider Monkey)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hunt Anthony	Director	May 15 '25	Sale	123.71	26,447	3,271,688	109,854	May 16 03:02 PM
Hunt Anthony	Director	May 15 '25	Proposed Sale	128.34	26,447	3,394,208		May 15 10:25 AM
Hunt Anthony	Director	Mar 17 '25	Option Exercise	54.73	26,756	1,464,267	163,057	Mar 19 04:21 PM
Hunt Anthony	Director	Mar 17 '25	Sale	152.51	26,756	4,080,663	136,301	Mar 19 04:21 PM
Pax Margaret	Director	Mar 17 '25	Buy	150.69	250	37,672	1,043	Mar 18 03:58 PM
Hunt Anthony	Director	Mar 17 '25	Proposed Sale	150.42	26,756	4,024,638		Mar 17 10:04 AM
Hunt Anthony	Director	Dec 05 '24	Option Exercise	33.87	11,808	399,937	151,648	Dec 05 08:26 PM
Hunt Anthony	Director	Nov 21 '24	Option Exercise	33.87	24,246	821,212	164,086	Nov 22 04:52 PM
Hunt Anthony	Director	Nov 21 '24	Sale	139.67	24,246	3,386,439	139,840	Nov 22 04:52 PM
Anthony Hunt	Executive Chairman	Nov 21 '24	Proposed Sale	139.66	24,246	3,386,311		Nov 21 03:52 PM
MUIR GLENN P	Director	Nov 19 '24	Option Exercise	36.29	19,000	689,510	32,283	Nov 20 02:29 PM
Hunt Anthony	Director	Sep 10 '24	Option Exercise	33.87	10,000	338,700	162,031	Sep 12 11:35 AM
Hunt Anthony	Director	Sep 10 '24	Sale	145.37	22,191	3,225,927	139,840	Sep 12 11:35 AM
Hunt Anthony	Officer	Sep 10 '24	Proposed Sale	144.72	22,191	3,211,481		Sep 10 04:03 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Option Exercise	86.10	175	15,067	12,463	Aug 05 09:56 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Sale	159.35	7,148	1,139,016	12,288	Aug 05 09:56 PM
Ralf Kuriyel	Senior Vice President	Aug 02 '24	Proposed Sale	159.35	7,148	1,139,040		Aug 02 03:26 PM
KURIYEL RALF	Senior VP, R&D	Aug 01 '24	Sale	165.67	4,465	739,717	19,261	Aug 01 08:47 PM
MUIR GLENN P	Director	Aug 01 '24	Option Exercise	36.29	5,000	181,450	13,283	Aug 01 05:04 PM
Christine Gebski	Senior Vice President	Aug 01 '24	Proposed Sale	167.00	2,160	360,720		Aug 01 04:11 PM
Ralf Kuriyel	Senior Vice President	Aug 01 '24	Proposed Sale	165.67	4,465	739,705		Aug 01 04:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RGEN

Repligen Corp

Upgrade your FINVIZ experience